MedFirst Healthcare Services, Inc. (TW)(TW:4175)
NT$49.35+0.45 (+0.71%)
TW:4175
MedFirst Healthcare Services, Inc. (TW) financials statements
NT$49.35
At close:+0.45 (+0.71%)
MedFirst Healthcare Services, Inc. (TW) (4175) Ratios
MedFirst Healthcare Services, Inc. (TW) Ratios
TW:4175's free cash flow for Q2 2026 was NT$388.61M. For the 2026 fiscal year, TW:4175's free cash flow was decreased by NT$-43.64M and operating cash flow was NT$432.25M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 0.83 | 0.75 | 0.85 | 0.82 | 0.87 |
| Quick Ratio | 0.31 | 0.32 | 0.45 | 0.46 | 0.47 |
| Cash Ratio | 0.15 | 0.18 | 0.31 | 0.32 | 0.29 |
| Solvency Ratio | 0.16 | 0.15 | 0.13 | 0.14 | 0.12 |
| Operating Cash Flow Ratio | 0.33 | 0.18 | 0.26 | 0.35 | 0.38 |
| Short-Term Operating Cash Flow Coverage | 2.62 | 0.81 | 1.82 | 2.15 | 3.20 |
| Net Current Asset Value | NT$ -3.45B | NT$ -3.43B | NT$ -3.61B | NT$ -3.65B | NT$ -3.33B |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.49 | 0.51 | 0.51 | 0.52 | 0.53 |
| Debt-to-Equity Ratio | 2.30 | 2.50 | 2.68 | 2.89 | 3.08 |
| Debt-to-Capital Ratio | 0.70 | 0.71 | 0.73 | 0.74 | 0.75 |
| Long-Term Debt-to-Capital Ratio | 0.37 | 0.32 | 0.42 | 0.44 | 0.54 |
| Financial Leverage Ratio | 4.67 | 4.88 | 5.27 | 5.54 | 5.80 |
| Debt Service Coverage Ratio | 2.36 | 1.24 | 1.72 | 1.64 | 1.98 |
| Interest Coverage Ratio | 3.44 | 2.09 | 1.80 | 5.72 | 2.54 |
| Debt to Market Cap | 0.50 | 0.48 | 0.41 | 0.57 | 0.71 |
| Interest Debt Per Share | 86.27 | 87.62 | 95.06 | 102.81 | 96.77 |
| Net Debt to EBITDA | 3.21 | 3.37 | 3.36 | 3.12 | 4.16 |
| Profitability Margins | |||||
| Gross Profit Margin | 32.46% | 30.81% | 30.47% | 30.53% | 29.46% |
| EBIT Margin | 2.63% | 2.00% | 1.72% | 3.72% | 1.47% |
| EBITDA Margin | 12.37% | 11.95% | 11.73% | 13.03% | 10.49% |
| Operating Profit Margin | 2.63% | 1.59% | 1.41% | 3.71% | 1.45% |
| Pretax Profit Margin | 2.33% | 1.23% | 0.94% | 3.07% | 0.90% |
| Net Profit Margin | 1.94% | 0.90% | 0.63% | 2.37% | 1.04% |
| Continuous Operations Profit Margin | 1.94% | 0.90% | 0.64% | 2.43% | 1.01% |
| Net Income Per EBT | 83.28% | 73.19% | 66.97% | 76.98% | 115.22% |
| EBT Per EBIT | 88.58% | 77.52% | 66.50% | 82.90% | 62.00% |
| Return on Assets (ROA) | 2.14% | 0.98% | 0.61% | 2.26% | 1.00% |
| Return on Equity (ROE) | 9.98% | 4.78% | 3.23% | 12.52% | 5.78% |
| Return on Capital Employed (ROCE) | 4.63% | 2.97% | 2.28% | 6.01% | 2.28% |
| Return on Invested Capital (ROIC) | 3.26% | 1.69% | 1.29% | 3.86% | 1.91% |
| Return on Tangible Assets | 2.14% | 0.98% | 0.62% | 2.27% | 1.00% |
| Earnings Yield | 6.21% | 2.52% | 1.31% | 6.19% | 2.85% |
| Efficiency Ratios | |||||
| Receivables Turnover | 31.93 | 31.83 | 28.36 | 25.57 | 29.90 |
| Payables Turnover | 4.30 | 4.33 | 3.52 | 3.56 | 3.66 |
| Inventory Turnover | 3.84 | 4.17 | 4.26 | 4.52 | 4.32 |
| Fixed Asset Turnover | 2.17 | 2.16 | 2.06 | 2.02 | 1.99 |
| Asset Turnover | 1.10 | 1.09 | 0.98 | 0.96 | 0.96 |
| Working Capital Turnover Ratio | -13.18 | -12.80 | -14.64 | -16.15 | -12.17 |
| Cash Conversion Cycle | 21.58 | 14.66 | -5.25 | -7.58 | -3.03 |
| Days of Sales Outstanding | 11.43 | 11.47 | 12.87 | 14.28 | 12.21 |
| Days of Inventory Outstanding | 95.10 | 87.48 | 85.61 | 80.68 | 84.58 |
| Days of Payables Outstanding | 84.95 | 84.29 | 103.73 | 102.54 | 99.82 |
| Operating Cycle | 106.53 | 98.95 | 98.47 | 94.96 | 96.79 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 21.38 | 12.83 | 19.20 | 27.59 | 26.50 |
| Free Cash Flow Per Share | 14.77 | 9.58 | 13.81 | 20.77 | 15.58 |
| Dividend Paid and CapEx Coverage Ratio | 2.60 | 2.64 | 2.42 | 3.34 | 2.10 |
| Capital Expenditure Coverage Ratio | 3.23 | 3.95 | 3.56 | 4.05 | 2.43 |
| Operating Cash Flow Coverage Ratio | 0.25 | 0.15 | 0.21 | 0.27 | 0.28 |
| Operating Cash Flow to Sales Ratio | 0.11 | 0.07 | 0.11 | 0.15 | 0.15 |
| Free Cash Flow Yield | 24.91% | 14.62% | 16.00% | 29.19% | 24.65% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 16.11 | 39.70 | 76.37 | 16.13 | 35.12 |
| Price-to-Sales (P/S) Ratio | 0.31 | 0.36 | 0.48 | 0.38 | 0.36 |
| Price-to-Book (P/B) Ratio | 1.61 | 1.90 | 2.47 | 2.02 | 2.03 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 4.01 | 6.84 | 6.25 | 3.43 | 4.06 |
| Price-to-Operating Cash Flow Ratio | 2.77 | 5.11 | 4.49 | 2.58 | 2.39 |
| Price-to-Earnings Growth (PEG) Ratio | 0.13 | 0.86 | -1.03 | 0.11 | -0.90 |
| Enterprise Value Multiple | 5.74 | 6.37 | 7.46 | 6.05 | 7.64 |
| Enterprise Value | 5.69B | 5.88B | 6.51B | 5.69B | 5.24B |
| EV to EBITDA | 5.74 | 6.37 | 7.46 | 6.05 | 7.64 |
| EV to Sales | 0.71 | 0.76 | 0.87 | 0.79 | 0.80 |
| EV to Free Cash Flow | 9.11 | 14.54 | 11.38 | 7.07 | 8.91 |
| EV to Operating Cash Flow | 6.29 | 10.85 | 8.19 | 5.32 | 5.24 |
| Tangible Book Value Per Share | 36.40 | 33.97 | 34.41 | 34.39 | 30.07 |
| Shareholders’ Equity Per Share | 36.89 | 34.52 | 34.94 | 35.20 | 31.12 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.17 | 0.27 | 0.32 | 0.21 | -0.12 |
| Revenue Per Share | 189.54 | 182.97 | 179.78 | 186.32 | 173.32 |
| Net Income Per Share | 3.68 | 1.65 | 1.13 | 4.41 | 1.80 |
| Tax Burden | 0.83 | 0.73 | 0.67 | 0.77 | 1.15 |
| Interest Burden | 0.89 | 0.62 | 0.54 | 0.83 | 0.61 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.30 | 0.29 | 0.29 | 0.27 | 0.28 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 4.84 | 5.68 | 16.99 | 4.82 | 14.72 |
Currency in TWD
